Technologies combining MRI, robotics, and artificial intelligence are changing the way prostate cancer is diagnosed and ...

The development and validation of a staging system for non-metastatic prostate cancer could help doctors and patients assess treatment options, as well as improve clinical trials. Doctors and ...

Healthcare integration was associated with small declines in treatment, but no change in overtreatment of prostate cancer. Integrated care delivery alone may be insufficient to curtail overtreatment.

In another step toward using artificial intelligence in medicine, a new study shows that computers can be trained to match human experts in judging the severity of prostate tumors. Researchers found ...

Prostate cancer screening is one of the most common decisions men face in primary care, yet many patients make that choice without fully understanding the potential benefits and harms. A new editorial ...

LATHAM, N.Y.--(BUSINESS WIRE)-- AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, ...

One of the most common concerns about treating prostate cancer is preserving sexual function and urinary control. For some prostate cancers, newer treatments offering an alternative to radiation and ...

DELRAY BEACH, Fla., May 2, 2017 /PRNewswire-USNewswire/ -- The Sperling Prostate Center is pleased to announce its participation as a new study site for a clinical study of MR-guided focused ...

The largest real-world study ever conducted on prostate cancer in Brazil analyzed data from 670,205 patients treated through ...

Doctors and biostatisticians at the University of Michigan Rogel Cancer Center have led the development and validation of a staging system to better predict outcomes and inform treatment decisions for ...